Alterola Biotech, Inc. (ABTI)
0.0051
0.00 (0.00%)
USD |
OTCM |
Jan 13, 16:00
Alterola Biotech Research and Development Expense (Quarterly): 0.017M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| NovoCure Ltd. | 54.03M |
| LivaNova Plc | 48.58M |
| Akanda Corp. | -- |
| Kiniksa Pharmaceuticals International Plc | 24.14M |
| Perspective Therapeutics, Inc. | 19.56M |